Share repurchase programs often lead to a positive market reaction as they can indicate a company's belief that its shares are undervalued and improve earnings per share (EPS) by reducing the number of shares outstanding. This announcement from Bristol Myers Squibb is likely to be viewed positively by investors, potentially leading to a short term increase in the stock price.